From the ∗Nuclear Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse

†Toulouse III–Paul Sabatier University

‡Department of Hematology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.

Received for publication September 29, 2023; revision accepted December 28, 2023.

All procedures performed in the present study were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Conflicts of interest and sources of funding: none declared.

Author Contributions: The study was designed by A.L. and S.Z. Material preparation and data collection were performed by A.L., M.K., L.V., and S.Z. The data analysis was performed by A.L. The first draft of the manuscript was written by A.L., and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Correspondence to: Adrien Latgé, MD, MSc, Department of Nuclear Medicine, Institut Claudius Regaud (ICR), Institut Universitaire du Cancer de Toulouse (IUCT), 1 Avenue Irène Joliot-Curie, 31100, Toulouse, France. E-mail: [email protected] / [email protected].